BRAZILIAN CONSENSUS STATEMENT ON VISCOSUPPLEMENTATION OF THE HIP (COBRAVI-Q)

Author:

SOUSA EDUARDO BRANCO DE1ORCID,HAMDAN PAULO CÉSAR2ORCID,MENEGASSI ZARTUR JOSÉ BARCELOS2ORCID,ALCHAAR ADRIENI ANTUNES DO AMARAL3ORCID,TIEPPO ANTONIO MARTINS4ORCID,SOUZA CAIO GONÇALVES DE5ORCID,PINHEIRO CARLOS BRUNO REIS2ORCID,ALMEIDA JÚNIOR CYRO SCALA DE4ORCID,ROCHA EDUARDO DE MELO CARVALHO4ORCID,CUNHA FABIANO GONÇALVES6ORCID,PACHECO IVAN7ORCID,REZENDE MARCIA UCHÔA DE5ORCID,SOUZA MÁRCIO PASSINI GONÇALVES DE5ORCID,BRITTO DA SILVA MARCOS2ORCID,CAMPOS GUSTAVO CONSTANTINO DE8ORCID

Affiliation:

1. Instituto Nacional de Traumatologia e Ortopedia, Brazil

2. Universidade Federal do Rio de Janeiro, Brazil

3. Hospital Municipal Miguel Couto, Brazil

4. Santa Casa de Misericórdia de São Paulo, Brazil

5. Universidade de São Paulo, Brazil

6. Hospital Santa Paula, Brazil

7. Hospital Moinhos de Vento, Brazil

8. Universidade Estadual de Campinas, Brazil

Abstract

ABSTRACT Objective: The Brazilian Consensus on Hip Viscosupplementation aims to generate a referential and consensual source from the theoretical knowledge and clinical experience of specialists in the field. Methods: A multidisciplinary panel was formed with 15 specialists (sports medicine, orthopedists, physiatrists and rheumatologists), based on clinical and academic experience in the use of viscosupplementation of the hip. 12 statements were prepared, discussed and voted. Each panelist gave a value between 0 and 10 on a Likert scale, specifying their level of agreement with the statement. Results: The panel reached a consensus on several aspects of viscosupplementation of the hip, with emphasis on the following statements: best indication is for mild to moderate hip arthrosis; it may be indicated in severe osteoarthritis; results may vary according to the characteristics of the viscosupplement used; Viscosupplementation should not be performed as an isolated procedure, but in conjunction with other rehabilitation and pharmacological measures; best injection technique should be based on anatomical references coupled with imaging guidance; it is a cost-effective procedure. Conclusion: Viscosupplementation is a safe and effective therapy for hip osteoarthritis, even in severe cases. Guided injection is recommended. Level of Evidence V, Expert Opinion.

Publisher

FapUNIFESP (SciELO)

Subject

Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation,Orthopedics and Sports Medicine

Reference40 articles.

1. Efficacy of a single intra-articular HYMOVIS ONE injection for managing symptomatic hip osteoarthritis a 12-month follow-up retrospective analysis of the ANTIAGE register data;Migliore A;Orthop Res Rev,2020

2. When is indicated viscosupplementation in hip osteoarthritis;Pogliacomi F;Acta Biomed,2019

3. Comparative, double blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip;Migliore A;Arthritis Res Ther,2009

4. Physician judgments of chronic pain patients;Tait RC;Soc Sci Med,1997

5. Idiopathic symptomatic osteoarthritis of the hip and knee a population-based incidence study;Wilson MG;Mayo Clin Proc,1990

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3